Drawing for PATIENTS FIRST

USPTO serial 99492717

PATIENTS FIRST

Reviewed by CopyMark Law Group

Status 661
Filing date
Status date
Registration date
—
Examiner
CALIENDO, COURTNEY MICHELLE
Law office
TMO LAW OFFICE 129

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PATIENTS FIRST?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Savannah Aronson, Esq.

27 Seaview BoulevardPort Washington, NY 11050United States

Goods and services

ClassDescriptionStatusFirst use
005FDA-regulated pharmaceutical products, namely, brand medicine, generic medicine, biologics and biosimilars, orphan drugs, over-the-counter drugs, controlled substances, vitamins, and supplements for the treatment of cardiovascular diseases; neurological disorders; psychiatric and psychological conditions; infectious diseases, namely, viral, bacterial, and fungal infections; HIV and hepatitis; oncological diseases and malignancies; dermatological conditions; pulmonary and respiratory disorders; nephrological diseases; gastrointestinal and hepatic conditions; hematologic disorders; reproductive and fertility-related conditions; immunological and allergic conditions; endocrine and metabolic disorders, namely, diabetes; musculoskeletal and orthopedic conditions; ophthalmologic disorders; transplant-related conditions and post-operative complications; all for the management of pain and other chronic or acute medical conditions.ACTIVE—
035Wholesale distributorship services featuring prescription and non-prescription pharmaceutical products, medical devices, and other FDA-regulated products for licensed pharmacies, hospitals, healthcare systems, and other institutional purchasers; wholesale ordering services in the field of prescription and non-prescription pharmaceutical preparations, dietary supplements, and medical devices for institutional purchasers; wholesale services by direct solicitation by sales agents in the field of prescription and non-prescription pharmaceutical preparations, dietary supplements, and medical devices for institutional purchasers; on-line wholesale store services featuring prescription and non-prescription pharmaceutical preparations, dietary supplements, and medical devices for institutional purchasers.ACTIVE—
041Providing educational services, namely, conducting information sessions in the nature of live presentations by educational speakers and training programs, directed to pharmacies and healthcare providers, in the field of pharmaceutical wholesaling and distribution best practices, patient safety, and medication adherence.ACTIVE—
042Quality control of pharmaceutical wholesale distribution services of others.ACTIVE—
044Providing health information to pharmacies and healthcare providers in the field of medication adherence, safe use of pharmaceuticals, and patient safetyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 18, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 18, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 18, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 1, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jul 1, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Apr 1, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 1, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 1, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 22, 2026DOCKASSIGNED TO EXAMINER—
Dec 18, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Dec 18, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 18, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 18, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 12, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 12, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 12, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance